|
negative regulation of leukocyte tethering or rolling
|
GO_1903237 |
[Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte tethering or rolling.] |
|
obsolete regulation of positive regulation of the force of heart contraction by chemical signal
|
GO_1903239 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of positive regulation of the force of heart contraction by chemical signal.] |
|
U2-type prespliceosome assembly
|
GO_1903241 |
[The aggregation, arrangement and bonding together of a set of components to form an U2-type prespliceosome.] |
|
obsolete negative regulation of positive regulation of the force of heart contraction by chemical signal
|
GO_1903240 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of positive regulation of the force of heart contraction by chemical signal.] |
|
negative regulation of cardiac muscle hypertrophy in response to stress
|
GO_1903243 |
[Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle hypertrophy in response to stress.] |
|
obsolete regulation of ATP catabolic process
|
GO_1903289 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of ATP catabolic process.] |
|
positive regulation of potassium ion import across plasma membrane
|
GO_1903288 |
[Any process that activates or increases the frequency, rate or extent of potassium ion import across the plasma membrane.] |
|
regulation of potassium ion import
|
GO_1903286 |
[Any process that modulates the frequency, rate or extent of potassium ion import.] |
|
obsolete negative regulation of ATP catabolic process
|
GO_1903290 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of ATP catabolic process.] |
|
protein localization to Golgi membrane
|
GO_1903292 |
[A process in which a protein is transported to, or maintained in, a location within a Golgi membrane.] |
|
obsolete positive regulation of ATP catabolic process
|
GO_1903291 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of ATP catabolic process.] |
|
regulation of glutamate secretion, neurotransmission
|
GO_1903294 |
[Any process that modulates the frequency, rate or extent of glutamate secretion, neurotransmission.] |
|
negative regulation of glutamate secretion, neurotransmission
|
GO_1903295 |
[Any process that stops, prevents or reduces the frequency, rate or extent of glutamate secretion, neurotransmission.] |
|
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway
|
GO_1903298 |
[Any process that stops, prevents or reduces the frequency, rate or extent of hypoxia-induced intrinsic apoptotic signaling pathway.] |
|
regulation of hypoxia-induced intrinsic apoptotic signaling pathway
|
GO_1903297 |
[Any process that modulates the frequency, rate or extent of hypoxia-induced intrinsic apoptotic signaling pathway.] |
|
negative regulation of ornithine catabolic process
|
GO_1903267 |
[Any process that stops, prevents or reduces the frequency, rate or extent of ornithine catabolic process.] |
|
regulation of ornithine catabolic process
|
GO_1903266 |
[Any process that modulates the frequency, rate or extent of ornithine catabolic process.] |
|
ornithine carbamoyltransferase inhibitor complex
|
GO_1903269 |
[A protein complex which is capable of ornithine carbamoyltransferase inhibitor activity.] |
|
positive regulation of ornithine catabolic process
|
GO_1903268 |
[Any process that activates or increases the frequency, rate or extent of ornithine catabolic process.] |
|
regulation of cytoplasmic translational elongation through polyproline stretches
|
GO_1903270 |
[Any process that modulates the frequency, rate or extent of cytoplasmic translational elongation through polyproline stretches.] |